Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Longwood Founders Fund
Biotech
Newleos unveils with $93M and 4 ex-Roche programs
Newleos' oversubscribed financing round was led by Goldman Sachs, with participation from Longwood Fund and Novo Holdings, among others.
Gabrielle Masson
Feb 13, 2025 12:00am
Pfizer-backed Dem gobbles up $70M to fund macrophage cancer R&D
Jun 23, 2022 7:50am
Carbon exits stealth with $38M to push CF drug to clinic
Jun 21, 2022 6:00am
Axial tops up funding for phase 2 autism trial with $37M round
Oct 13, 2021 7:00am
Bluebird bio alums bolster Be Biopharma's leadership team
Mar 16, 2021 4:05pm
TScan adds another $100M to the pot for TCR therapies
Jan 25, 2021 8:20am
